Kwok Pang is the Chief Operating officer for Autolomous, a software and technology
platform for CGT manufacturing. Autolomous internationally deploys fully integrated,
digitized and automated supply chain software solutions. These solutions utilize emerging
technologies such as Ledger technology and Internet of Things (IoT) to ensure compliance
with current and future regulatory requirements.
Prior to Autolomous, Kwok was part of the Cell & Gene Therapy Catapult (CGT)
manufacturing centre team that established the multi- user, multi-product GMP
manufacturing facility. Between 2002- 2017, he held roles at GSK’s Cell & Gene Therapy
team and the Royal Free London NHS Trust’s Centre for Cell, Gene, Tissue Therapies
(CCGTT). He has a wealth of experience in CGT manufacturing, digitisation of CGT
manufacturing processes and building collaboration within the CGT ecosystem.